The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

Enphase Energy (ENPH) retained its spot as the most shorted S&P 500 (SP500) stock as a percentage of float in July, followed ...

Mixed options sentiment in Moderna (MRNA), with shares down 9c near $26.80. Options volume relatively light with 20k contracts traded and calls ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

Over the past six months, Moderna’s shares (currently trading at $25.79) have posted a disappointing 19.2% loss, well below ...

We recently published 10 Stocks Jim Cramer Mentioned As He Talked About “Love Lost” Between Microsoft & OpenAI. Moderna, Inc. (NASDAQ:MRNA) is one of the stocks Jim Cramer recently discussed.

Moderna’s second quarter results were met with a negative market reaction, as investors focused on both a sharp decline in ...

RFK Jr. canceled nearly $500 million in mRNA vaccine research funding. Plus, the latest climate news, from flooding in Alaska ...

Moderna may offer substantial upside, but it's essential to consider the associated risks. Since hitting their peak in late ...

Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...